Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Breast Neoplasms 14Esophageal Neoplasms 5Adenocarcinoma Of Esophagus 5Lung Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Sarcoma 3Rectal Neoplasms 3Colorectal Neoplasms 3Carcinoma, Intraductal, Noninfiltrating 3Squamous Cell Carcinoma of Head and Neck 2Prostatic Neoplasms 2Pancreatic Neoplasms 2Osteosarcoma 2Multiple Myeloma 2Kidney Neoplasms 2Head and Neck Neoplasms 2Esophageal Squamous Cell Carcinoma 2Carcinoma, Renal Cell 2Breast Carcinoma In Situ 2Vomiting 1Urologic Neoplasms 1Urogenital Neoplasms 1Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Teratoma 1Stomach Neoplasms 1Sarcoma, Alveolar Soft Part 1Rhabdomyosarcoma 1Prostate Adenocarcinoma 1Ovarian Neoplasms 1

Interventions

Carboplatin 12Bevacizumab 10Radiotherapy 9Paclitaxel 9Erlotinib Hydrochloride 9Pemetrexed 7Docetaxel 5Taxes 4Cisplatin 4pegfilgrastim 3Gemcitabine 3Cetuximab 3Radiotherapy, Conformal 2Filgrastim 2veliparib 1romidepsin 1pegylated granulocyte colony-stimulating factor 1lentiviral minigene vaccine of COVID-19 coronavirus 1Watchful Waiting 1Vinorelbine 1Topotecan 1Thalidomide 1Temozolomide 1Surgical Procedures, Operative 1Sorafenib 1Selenomethionine 1Radiotherapy, Intensity-Modulated 1Radiosurgery 1Radiation 1Pneumonectomy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Adenocarcinoma, Bronchiolo-Alveolar × Neoadjuvant Therapy × Clear all
NCT00113386 2013-06-28

Cisplatin and Docetaxel With or Without Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Newly Diagnosed Stage III Non-Small Cell Lung Cancer

Radiation Therapy Oncology Group

Phase 3 Terminated
19 enrolled 5 charts
Thoracic

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡